0001562180-21-001149.txt : 20210212
0001562180-21-001149.hdr.sgml : 20210212
20210212215112
ACCESSION NUMBER: 0001562180-21-001149
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREGORY JULIA P
CENTRAL INDEX KEY: 0001226675
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 21631635
MAIL ADDRESS:
STREET 1: 8800 TECHNOLOGY FOREST PLACE
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
5
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
5
2020-12-31
false
0
1
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001226675
GREGORY JULIA P
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
true
false
false
false
Common Shares
2020-07-01
4
M
false
L
18000.00
28.76
A
18000.00
D
Common Shares
2020-07-01
4
S
false
L
14400.00
71.2001
D
3600.00
D
Common Shares
2020-07-01
4
S
false
L
3600.00
72.559
D
0.00
D
Stock Option (Right to Buy)
28.76
2020-07-01
4
M
false
L
18000.00
0.00
D
2019-05-01
2028-04-30
Common Shares
18000.00
0.00
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.73 - $71.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.1996 - $72.9850, inclusive.
/s/ Jim Engelhart, Attorney-in-Fact
2021-02-12